To assess the relevance of HBe/anti-HBe system and DNA polymerase activity in patients on regular dialysis treatment, we prospectively studied 38 patients on haemodialysis, who were chronic carriers of HBs Ag (range 6-66 months), and 26 HBs Ag negative dialysis patients as controls. HBe Ag was present in 74%, DNA polymerase in 60%, and anti-HBe in 13 of HBs Ag positive patients. After a mean follow-up of 23.5 months, only 2 patients, who had been HBe Ag positive, had cleared HBs Ag and 1 of them had turned to anti-HBs positivity. Among the patients who were still HBs Ag positive, only 1 had lost HBe Ag, without developing anti-HBe. Throughout the study, SGOT and SGPT levels were significantly raised in HB virus carriers as compared to controls. In the HBs Ag positive group, the presence of HBe Ag and/or DNA polymerase characterized a subgroup with the most striking abnormalities in enzyme levels. The causes of death in the HBs Ag positive group were not related to liver disease. Viral replication usually takes place in HB virus carriers on haemodialysis and is associated with biochemical evidence of liver-cell damage. However, the HB virus carrier state, and the underlying liver disease are not major problems at present in patients on chronic haemodialysis.

Relevance of HBe/anti-HBe system and of DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis / G. MARCHESINI, M. ZOLI, A. ANGIOLINI, G. FELICIANGELI, A. SANTORO, P. FERRONI, A.R. ZANETTI. - In: NEPHRON. - ISSN 0028-2766. - 29:1-2(1981), pp. 44-48.

Relevance of HBe/anti-HBe system and of DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis

A.R. ZANETTI
Ultimo
1981

Abstract

To assess the relevance of HBe/anti-HBe system and DNA polymerase activity in patients on regular dialysis treatment, we prospectively studied 38 patients on haemodialysis, who were chronic carriers of HBs Ag (range 6-66 months), and 26 HBs Ag negative dialysis patients as controls. HBe Ag was present in 74%, DNA polymerase in 60%, and anti-HBe in 13 of HBs Ag positive patients. After a mean follow-up of 23.5 months, only 2 patients, who had been HBe Ag positive, had cleared HBs Ag and 1 of them had turned to anti-HBs positivity. Among the patients who were still HBs Ag positive, only 1 had lost HBe Ag, without developing anti-HBe. Throughout the study, SGOT and SGPT levels were significantly raised in HB virus carriers as compared to controls. In the HBs Ag positive group, the presence of HBe Ag and/or DNA polymerase characterized a subgroup with the most striking abnormalities in enzyme levels. The causes of death in the HBs Ag positive group were not related to liver disease. Viral replication usually takes place in HB virus carriers on haemodialysis and is associated with biochemical evidence of liver-cell damage. However, the HB virus carrier state, and the underlying liver disease are not major problems at present in patients on chronic haemodialysis.
Settore MED/42 - Igiene Generale e Applicata
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/185795
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact